Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 38.24M P/E - EPS this Y 9.80% Ern Qtrly Grth -
Income -63.97M Forward P/E -0.82 EPS next Y -19.10% 50D Avg Chg -3.00%
Sales - PEG -0.01 EPS past 5Y - 200D Avg Chg -17.00%
Dividend N/A Price/Book 0.22 EPS next 5Y 59.00% 52W High Chg -72.00%
Recommedations 2.00 Quick Ratio 7.94 Shares Outstanding 41.09M 52W Low Chg 30.00%
Insider Own 6.52% ROA -26.82% Shares Float 20.83M Beta 1.31
Inst Own 62.47% ROE -44.22% Shares Shorted/Prior 3.85K/8.42K Price 0.97
Gross Margin - Profit Margin - Avg. Volume 110,488 Target Price 2.83
Oper. Margin - Earnings Date Nov 11 Volume 33,280 Change -4.66%
About Achilles Therapeutics plc

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Achilles Therapeutics plc News
11/19/24 US Penny Stocks To Watch In November 2024
11/19/24 Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
11/14/24 Achilles Therapeutics Reports Third Quarter 2024 Financial Results
09/23/24 Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?
09/19/24 Achilles Therapeutics Announces Strategic Update
08/14/24 Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?
08/14/24 Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
05/22/24 Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
05/17/24 Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
05/08/24 Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
04/04/24 Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
04/04/24 Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
02/09/24 Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?
02/05/24 Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
01/24/24 Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
12/18/23 Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
ACHL Chatroom

User Image Magic8BallResponse Posted - 22 hours ago

$CABA Beginning to look like $ADAP $ACHL $BLUE ..... Runway is important and 2026 is closing in

User Image HoHoHoHum Posted - 5 days ago

$ACHL i thought this would have rallied based on the potential liquidation value. But so far nada. Any thoughts?

User Image HoHoHoHum Posted - 5 days ago

$ACHL how long is it going to take for the liquidation?

User Image DonCorleone77 Posted - 1 week ago

$ACHL Achilles Therapeutics reports Q3 EPS (48c) vs. (42c) last year Following the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials, the Company has engaged BofA Securities as a financial advisor in the process of exploring strategic options.

User Image AvaAsset Posted - 1 week ago

MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. HUGE PR drop incoming before the Nov 13 meeting, so compliance is coming, no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7. CEO teased big plans ahead. 8.Offering Deal $ACHL $DRRX

User Image HitItHard3585 Posted - 2 weeks ago

$ACHL Being loaded into close. Daily and weekly curling bullish.

User Image stockusfrance Posted - 10/22/24

$ACHL on watch

User Image Bobby_J_Bomb Posted - 1 month ago

$AADI $ACHL $ONCT $KZR Strategic alternative take a while. $SPRB has data in Q4 for 2 late phase large end market indications. If successful, will almost certainly have a massive spike of at least 200%. If not, they will likely be the next cash rich company to join this group and possibly get a spike for premium to cash at trading around 30% cash value.

User Image GSMITH10107 Posted - 1 month ago

$SPRB they have 3 x their market cap in cash as of today - actually a little bit more . they are burning ~ 8 mil a quarter. the best opportunity in the bio space ive seen in a long time. better than $achl strategic alternatives. Why? because we have topline data (that may or may not work) and then a safety net of the massive cash pile. Liquidation/merger would pay us massively. solid data would pay us massively from these levels. and the best part? the catalyst is coming any day (Q4 2024) we ARE IN Q4 2024.

User Image Magic8BallResponse Posted - 1 month ago

@The_Sunset_Investor I would look to $ACHL as an example.

User Image Ulong Posted - 09/28/24

$ACHL Short, Medium and Long strong bullish💪

User Image GSMITH10107 Posted - 09/27/24

$SPRB yup. if they fail .. (thats a big IF) in q4 watch strategic alternatives - you cannot ignore the cash. co will most likely dissolve given nothing else worthwhile in the pipeline. its like $ACHL on steroids. you get the free data play + the cash to fall back on..

User Image prismmarketview Posted - 09/27/24

$KOD $LVTX $GLTO $ACHL https://prismmarketview.com/biotechs-vital-signs-a-pulse-on-recovery-and-growth-opportunities/#more-1767121

User Image Longroader Posted - 09/26/24

$ACHL Getting more love here. BML 9.97%

User Image joe77w Posted - 09/24/24

$ACHL back to 80 , It Will take a long time to liquidate, cash burn still High, workers layoffs Will be costly imo

User Image GSMITH10107 Posted - 09/24/24

$SPRB they didn't want $ARDX which dropped to .50 cents then went to 9$ in a short period of time they laughed at $FNCH which went from .88 to $16.74 they laughed at $ACHL which went from .63 to $1.06 I believe $SPRB is laughably undervalued. assuming they burned 10 million this quarter, thay are headed into topline data with 60 million cash and approx 3 million in debt at a 17 million dollar market cap heads you win tails you win?? postive data = multibagger, strategic alternatives = multibagger IMO

User Image GSMITH10107 Posted - 09/23/24

$SPRB $ACHL I will keep buying the dips on this one. they could liquidate RIGHT NOW for multiples - last balance sheet at 6/30/24 69.6 million cash and 3.6 million in total debt according to yahoo. you can do the math

User Image GSMITH10107 Posted - 09/23/24

$SPRB makes no sense. approx 60 million cash as of today and two sets of ph.3 data coming Q4 .. my top bio play for 2024 .. with a fail they could liquidate/strategic alternatives like $ACHL , with positive data, it's a pretty big market.. ill wait.. trading at 18 million market cap - 3X less cash? with a chance for a homerun on data??

User Image RallyRaider Posted - 09/22/24

$ACHL super action new high coming

User Image WendyPowera Posted - 09/22/24

$ACHL Early Investors in this $1.22 stock could turn $10k into $55k Join StockVerse for exclusive stock alerts! 💰 check it out here https://stockverse.com/alerts

User Image Ned_Nosurname Posted - 2 months ago

$TSBX Interesting, evidence indicates that the clonality and quality, but not quantity, of neoantigens are critical for immunotherapy efficacy $ACHL https://www.science.org/doi/10.1126/scitranslmed.aax7918

User Image Game_Day Posted - 2 months ago

Sep 20 new alerts 🏝️ Great weekend everyone $TNON ⭐️ 15-30% gain range, ah buy zone alert to massive am pop 3 great exits/reduce above money shot 8.50 8.00 and 7.50 $ACHL ⭐️ 5-7% gain range beautiful low float play leg up before ph $BA ⭐️ active new calls from 153 line zone with current cross at 153.90

User Image Bigstocka Posted - 2 months ago

$ACHL DEAD ON $0.9999 🤬🤬🤬

User Image Infinitefreedom Posted - 2 months ago

$ACHL everyone is sleeping right now but will wake up when this goes above $1.05 imo

User Image Infinitefreedom Posted - 2 months ago

$ACHL once this goes above $1 the sky is the limit imo

User Image Bigstocka Posted - 2 months ago

$ACHL SOLD THAT CRAP

User Image GSMITH10107 Posted - 2 months ago

$SPRB i bought some . liquidate this POS like $ACHL and give shareholders the cash. thank you.

User Image Bigstocka Posted - 2 months ago

$ACHL IF IT BREAKS 1.08 then we are talking money

User Image Infinitefreedom Posted - 2 months ago

$ACHL I believe this will move higher today. Above $1.05

User Image Bigstocka Posted - 2 months ago

$ACHL WELL IM HOLDING NOT GOING TO SELL UNTIL IT GOES OVER $1 TODAY, AND IT LOOKS LIKE IT WILL

Analyst Ratings
Chardan Capital Buy Apr 5, 24
Piper Sandler Neutral Apr 5, 24
B of A Securities Underperform Dec 14, 23
Chardan Capital Buy Aug 7, 23
Chardan Capital Buy May 11, 23
Chardan Capital Buy Dec 7, 22
Piper Sandler Overweight Dec 7, 22
JP Morgan Underweight Apr 26, 21
B of A Securities Buy Apr 26, 21